FDA Oral Contraceptive Label Guidance Removes Mention Of Emergency Use
FDA's revised draft guidance on labeling for combined oral contraceptives removes dosing information on emergency use of the products
You may also be interested in...
FDA is nearing completion of guidance on labeling for combined oral contraceptives with an eye toward improving communication with more visual presentations rather than relying on prose.
FDA should not require information regarding emergency contraception uses be included in labeling for combined oral contraceptives, the Pharmaceutical Research & Manufacturers of America stated in comments on a draft FDA guidance.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011